Skip Navigation

European Heart Journal 2000 21(2):104-115; doi:10.1053/euhj.1999.1701
Copyright © 2000 by the European Society of Cardiology.
This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Weiss, B.M
Right arrow Articles by Hess, O.M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, B.M
Right arrow Articles by Hess, O.M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Review

Pulmonary vascular disease and pregnancy: current controversies, management strategies, and perspectives

B.M Weissa,f1 and O.M Hessb

a Department of Anaesthesiology, Unversity Hospital, Zürich, Switzerland
b Swiss Heart Center, Unversity Hospital, Inselspital Bern, Switzerland

Key Words: Pregnancy, pulmonary vascular disease, Eisenmenger's syndrome, primary pulmonary hypertension, secondary pulmonary hypertension, mitral valve stenosis

f1 Correspondence: Branko M. Weiss, MD, Department of Anaesthesiology, University Hospital, Rämistrasse 100, CH-8091 Zurich, Switzerland.

References

  1. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial study of factors influencing changes in cardiac output during human pregnancy. Am J Physiol. 1989;256:H1060–H1065[Web of Science][Medline]
  2. Capeless EL, Clapp JF. Cardiovascular changes in early phase of pregnancy. Am J Obstet Gynecol. 1989;161:1449–1453[Web of Science][Medline]
  3. Phippard AF, Horvath JS, Glynn EM. Circulatory adaptation to pregnancy—serial studies of haemodynamics, blood volume, renin and aldosterone in the baboon (Papio hamadryas). J Hypertens. 1986;4:773–779[CrossRef][Web of Science][Medline]
  4. Schrier RW, Durr JA. Pregnancy: an overfill or underfill state. Am J Kidney Dis. 1987;9:284–289[Web of Science][Medline]
  5. Chapman AB, Abraham WT, Zamudio S. Temporal relationship between hormonal and hemodynamic changes in early human pregnancy. Kidney Int. 1998;54:2056–2063[CrossRef][Web of Science][Medline]
  6. Duvekot JJ, Peeters LLH. Maternal cardiovascular hemodynamic adaptation to pregnancy. Obstet Gynecol Surv. 1994;49:S1–S14[CrossRef][Medline]
  7. Bonica JJ. Maternal anatomic and physiologic alterations during pregnancy and parturition. Bonica JJ, McDonald JS. Practice of Obstetric Analgesia and Anesthesia. Baltimore: Williams & Wilkins; 1995. p. 45–82
  8. Poppas A, Shroff SG, Korcarz CE. Serial assessment of the cardiovascular system in normal pregnancy. Role of arterial compliance and pulsatile arterial load. Circulation. 1997;95:2407–2415[Abstract/Free Full Text]
  9. van Oppen ACC, Stigter RH, Bruinse HW. Cardiac output in normal pregnancy: a critical review. Obstet Gynecol. 1996;87:310–318[CrossRef][Web of Science][Medline]
  10. Mone SM, Sanders SP, Colan SD. Control mechanisms for physiological hypertrophy of pregnancy. Circulation. 1996;94:667–672[Abstract/Free Full Text]
  11. Robson SC, Hunter S, Boys RJ, Dunlop W. Serial changes in pulmonary haemodynamics during human pregnancy: a non-invasive study using Doppler echocardiography. Clin Sci Colch. 1991;80:113–117[Medline]
  12. Hunter S, Robson SC. Adaptation of the maternal heart in pregnancy. Br Heart J. 1992;68:540–543[Free Full Text]
  13. Robson SC, Hunter S, Moore M, Dunlop W. Haemodynamic changes during the puerperium: a Doppler and M-mode echocardiographic study. Br J Obstet Gynaecol. 1987;94:1028–1029[Web of Science][Medline]
  14. Clapp JF 3rd, Capeless E. Cardiovascular function before, during, and after the first and subsequent pregnancies. Am J Cardiol. 1997;80:1469–1473[CrossRef][Web of Science][Medline]
  15. Hankins GDV, Clark SL, Uckran E, Van Hook JW. Maternal oxygen transport variables during the third trimester of normal pregnancy. Am J Obstet Gynecol. 1999;180:406–409[CrossRef][Web of Science][Medline]
  16. Weiss BM, Biro P. Kardiovaskuläre Erkrankungen. Alon E. Anästhesie und Schmerzlinderung in der Geburtshilfe. Bern: Hans Huber; 1996. p. 192–222
  17. Lewis, G, Drife, J, Botting, B, Why mothers die, London, Department of Health and Her Majesty's Stationery Office, 1998
  18. Avila WS, Grinberg M. Gestaço em portadoras de afecçes cardiovasculare. Experiênca com 1000 casos. Arq Bras Cardiol. 1993;60:5–11[Medline]
  19. Presbitero P, Somerville J, Stone S, Aruta E, Spiegelhalter D, Rabajoli F. Pregnancy in cyanotic congenital heart disease. Outcome of mother and fetus. Circulation. 1994;89:2673–2676[Abstract/Free Full Text]
  20. Meyer NE, Mercer B, Khoury A, Sibai B. Pregnancy complicated by cardiac disease. Maternal and perinatal outcome. J Maternal-Fetal Med. 1994;3:31–36
  21. McCaffrey FM, Sherman FS. Pregnancy and congenital heart disease; the Magee-Women's Hospital. J Maternal-Fetal Med. 1995;4:152–159
  22. Oliveira TA, Avila WS, Grinberg M. Obstetric and perinatal aspects in patients with congenital heart disease. Rev Paul Med. 1996;114:1248–1254
  23. Chia YT, Yeoh SC, Viegas OA, Lim M, Ratnam SS. Maternal congenital heart disease and pregnancy outcome. J Obstet Gynaecol Res. 1996;22:185–191[Medline]
  24. Siu SC, Sermer M, Harrison DA. Risk and predictors for pregnancy-related complications in women with heart disease. Circulation. 1997;96:2789–2794[Abstract/Free Full Text]
  25. Gleicher N, Midwall J, Hochberger D, Jaffin H. Eisenmenger's syndrome and pregnancy. Obstet Gynecol Surv. 1979;34:721–741[Medline]
  26. Sbarouni E, Oakley CM. Outcome of pregnancy in women with valve protheses. Br Heart J. 1994;71:196–201[Abstract/Free Full Text]
  27. Canobbio MM, Mair DD, van der Velde M, Koos BJ. Pregnancy outcomes after the Fontan repair. J Am Coll Cardiol. 1996;28:763–767[Abstract]
  28. Neumayer U, Somerville J. Outcome of pregnancies in patients with complex pulmonary atresia. Heart. 1997;78:16–21[Abstract/Free Full Text]
  29. Dore A, Somerville J. Pregnancy in patients with pulmonary autograft valve replacement. Eur Heart J. 1997;18:1659–1662[Abstract/Free Full Text]
  30. Weiss BM, Zemp L, Seifert B, Hess OM. Outcome of pulmonary vascular disease in pregnancy: a systematic overview from 1978 through 1996. J Am Coll Cardiol. 1998;31:1650–1657[Abstract/Free Full Text]
  31. Arora R, Kalra GS, Murty GSR. Percutaneous transatrial mitral commissurotomy: immediate and intermediate results. J Am Coll Cardiol. 1994;23:1327–1332[Abstract]
  32. Weiss BM, von Segesser LK, Alon E, Seifert B, Turina MI. Outcome of cardiovascular surgery and pregnancy: a systematic review of the period 1984–1996. Am J Obstet Gynecol. 1998;179:1643–1653[CrossRef][Web of Science][Medline]
  33. Grossman W, Braunwald E. Pulmonary hypertension. Braunwald E. Heart Disease. A Textbook of Cardiovascular Medicine. Philadelphia: WB Saunders; 1992. p. 790–816
  34. Hopkins WE, Ochoa LL, Richardson GW, Trulock EP. Comparison of the hemodynamics and survival of adults with severe primary pulmonary hypertension or Eisenmenger syndrome. J Heart Lung Transplant. 1996;15:100–105[Web of Science][Medline]
  35. Somerville J. How to manage the Eisenmenger syndrome. Int J Cardiol. 1998;63:1–8[CrossRef][Web of Science][Medline]
  36. Carabello BA, Crawford FA Jr. Valvular heart disease. N Engl J Med. 1997;337:32–41[Free Full Text]
  37. Mandinov, L, Aeschbacher, B, Hess, OM, Mitral valve disease, Dalla-Volta, S, Bayes de Luna, A, Brochier, M, Cardiology, New York, McGraw-Hill, 1999, 9, 1, 14
  38. Alpert MA, Goldberg SH, Singsen BH. Cardiovascular manifestations of mixed connective tissue disease in adults. Circulation. 1983;68:1182–1193[Abstract/Free Full Text]
  39. Morgan JM, Griffiths M, du Bois RM, Evans TW. Hypoxic pulmonary vasoconstriction in systemic sclerosis and primary pulmonary hypertension. Chest. 1991;99:551–556[CrossRef][Web of Science][Medline]
  40. Abenheim L, Moride Y, Brenot F. Appetite-suppressant drugs and the risk of primary pulmonary hypertension. N Engl J Med. 1996;335:609–616[Abstract/Free Full Text]
  41. Petitpretz P, Brenot F, Azarian R. Pulmonary hypertension in patients with human immunodeficiency virus infection. Comparison with primary pulmonary hypertension. Circulation. 1994;89:2722–2727[Abstract/Free Full Text]
  42. Opravil M, Pechere M, Speich R. HIV-associated primary pulmonary hypertension. A case control study. Am J Respir Crit Care Med. 1997;155:990–995[Abstract]
  43. Elstein D, Klutstein MW, Lahad A, Abrahamov A, Hadas-Halpern I, Zimran A. Echocardiographic assessment of pulmonary hypertension in Gaucher's disease. Lancet. 1998;351:1544–1546[CrossRef][Web of Science][Medline]
  44. Gaine SP, Rubin LJ. Primary pulmonary hypertension. Lancet. 1998;352:719–725[CrossRef][Web of Science][Medline]
  45. McLaughlin VV, Rich S. Pulmonary hypertension— advances in medical and surgical interventions. J Heart Lung Transpl. 1998;17:739–743[Web of Science][Medline]
  46. Penny WF, Weinstein M, Saltzman EW, Ware JA. Correlation of circulating von Willebrand factor levels with cardiovascular hemodynamics. Circulation. 1991;83:1630–1636[Abstract/Free Full Text]
  47. Lopes AA, Maeda NY, Bydlowski SP. Abnormalities in circulating von Willebrand factor and survival in pulmonary hypertension. Am J Med. 1998;105:21–26[CrossRef][Web of Science][Medline]
  48. Wood P. The Eisenmenger syndrome or pulmonary hypertension with reversed central shunt. Br Med J. 1958;2:701–709[Free Full Text]
  49. Collins-Nakai RL, Rabinovitch M. Pulmonary vascular obstructive disease. Cardiol Clin. 1993;11:675–687[Medline]
  50. Kidd L, Driscoll DJ, Gersony WM. Second natural history study of congenital heart defects. Results of treatment of patients with ventricular septal defects. Circulation. 1993;87:I-38–I-51[Medline]
  51. Saha A, Balakrishnan KG, Jaiswal PK. Prognosis for patients with Eisenmenger syndrome of various aetiology. Int J Cardiol. 1994;45:199–207[CrossRef][Web of Science][Medline]
  52. Daliento L, Somerville J, Presbitero P. Eisenmenger syndrome. Factors relating to deterioration and death. Eur Heart J. 1998;19:1845–1855[Abstract/Free Full Text]
  53. Niwa K, Perioff JK, Kaplan S, Child JS, Miner PD. Eisenmenger syndrome in adults: ventricular septal defect, truncus arteriosus, univentricular heart. J Am Coll Cardiol. 1999;34:223–232[Abstract/Free Full Text]
  54. Smedstad K, Cramb R, Morison DH. Pulmonary hypertension and pregnancy: a series of eight cases. Can J Anaesth. 1994;41:502–512[Web of Science][Medline]
  55. Avila WS, Grinberg M, Snitcowsky R. Maternal and fetal outcome in pregnant women with Eisenmenger's syndrome. Eur Heart J. 1995;16:460–464[Abstract/Free Full Text]
  56. Tahir H. Pulmonary hypertension, cardiac disease and pregnancy. Int J Gynecol Obstet. 1995;51:109–113[CrossRef][Medline]
  57. Bosatra MG, Passarani S, Marino MR, Marcolin R, Fumagalli R, Pesenti A. Caesarean delivery of a patient with truncus arteriosus. Int J Obstet Anesth. 1997;6:279–284[CrossRef][Web of Science][Medline]
  58. Goldsmith RJ, Henderson JL, Reynolds JD, Penning DH. Management of a parturient with an uncorrected atrioventricular canal defect. Int J Obstet Anesth. 1998;7:181–184[CrossRef][Web of Science][Medline]
  59. Goodwin TM, Gherman RB, Hameed A, Eikayam U. Favorable response of Eisenmenger syndrome to inhaled nitric oxide during pregnancy. Am J Obstet Gynecol. 1999;180:64–67[CrossRef][Web of Science][Medline]
  60. Yentis SM, Steer PJ, Plaat F. Eisenmenger's syndrome in pregnancy: maternal and fetal mortality in the 1990's. Br J Obstet Gynaecol. 1998;105:921–922[Web of Science][Medline]
  61. Wight E, Noll G, Lüscher TF. Regulation of vascular tone and endothelial function and its alterations in cardiovascular disease. Baillière's Clin Anaesth. 1997;11:531–560
  62. Christman BW, McPherson CD, Newman JH. An imbalance of the excretion of thromboxane and prostacyclin metabolites in pulmonary hypertension. N Engl J Med. 1992;327:70–75[Abstract]
  63. Giaid A, Saleh D. Reduced expression of endothelial nitric oxide synthase in the lungs of patients with pulmonary hypertension. N Engl J Med. 1995;333:214–221[Abstract/Free Full Text]
  64. Rabinovitch M. Novel mediators of pulmonary vascular pathobiology. Schwinn DA. New Advances in Vascular Biology and Molecular Cardiovascular Medicine. Baltimore: Williams & Wilkins; 1998. p. 49–68
  65. Cool CD, Kenedy D, Voelkel NF, Tuder RM. Pathogenesis and evolution of plexiform lesions in pulmonary hypertension associated with scleroderma and human immunodeficiency virus infection. Hum Pathol. 1997;28:434–442[CrossRef][Web of Science][Medline]
  66. Hassell KL. Altered hemostasis in pulmonary hypertension. Blood Coagul Fibrinolysis. 1998;9:107–117[Web of Science][Medline]
  67. Williamson DJ, Hayward C, Rogers P. Acute hemodynamic responses to inhaled nitric oxide in patients with limited scleroderma and isolated pulmonary hypertension. Circulation. 1996;94:477–482[Abstract/Free Full Text]
  68. Hinderliter AL, Willis PW IV, Barst RJ. Effects of long-term infusion of prostacyclin (epoprostenol) on echocardiographic measures of right ventricular structure and function in primary pulmonary hypertension. Circulation. 1997;95:1479–1486[Abstract/Free Full Text]
  69. McLaughlin VV, Genthner DE, Panella MM, Rich S. Reduction in pulmonary vascular resistance with long-term epoprostenol (prostacyclin) therapy in primary pulmonary hypertension. N Engl J Med. 1998;338:273–277[Abstract/Free Full Text]
  70. Rich S. Clinical insights into the pathogenesis of primary pulmonary hypertension. Chest. 1998;114:237S–241S[CrossRef][Medline]
  71. Lee SD, Shroyer KR, Markham NE, Cool CD, Voelkel NF, Tuder RM. Monoclonal endothelial cell proliferation is present in primary but not secondary pulmonary hypertension. J Clin Invest. 1998;101:927–934[Web of Science][Medline]
  72. Endrys J, Hayat N, Cherian G. Comparison of brochopulmonary collaterals and collateral blood flow in patients with chronic thromboembolic and primary pulmonary hypertension. Heart. 1997;78:171–176[Abstract/Free Full Text]
  73. Martinuzzo ME, Pombo G, Forastiero RR, Cerrato GS, Colorio CC, Carreras LO. Lupus anticoagulant, high levels of anticardiolipin and anti-ß2-glycoprotein I antibodies are associated with chronic thromboembolic pulmonary hypertension. J Rheumatol. 1998;25:1313–1319[Web of Science][Medline]
  74. Miyata M, Suzuki K, Sakuma F. Anticardiolipin antibodies are associated with pulmonary hypertension in patients with mixed connective tissue disease or systemic lupus erythematosus. Int Arch Allergy Immunol. 1993;100:351–354[Web of Science][Medline]
  75. Ordi-Ros J, Perez-Peman P, Monasterio J. Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies). Haemostasis. 1994;24:165–174[Web of Science][Medline]
  76. Roldan CA, Shively BK, Crawford MH. An echocardiographic study of valvular heart disease associated with systemic lupus erythematosus. N Engl J Med. 1996;335:1424–1430[Abstract/Free Full Text]
  77. Hojnik M, George J, Ziporen L, Shoenfeld Y. Heart valve involvement (Libman-Sacks endocarditis) in the antiphospholipid syndrome. Circulation. 1996;93:1579–1587[Abstract/Free Full Text]
  78. Glanville AR, Burke CM, Theodore J, Robin ED. Primary pulmonary hypertension. Length of survival in patients referred for heart-lung transplantation. Chest. 1987;91:675–681[CrossRef][Web of Science][Medline]
  79. Brenot F. Primary pulmonary hypertension. Case series from France. Chest. 1994;105:33S–36S[Medline]
  80. Rozkovec A, Montanes P, Oakley CM. Factors that influence the outcome of primary pulmonary hypertension. Br Heart J. 1986;55:449–458[Abstract/Free Full Text]
  81. Sagie A, Freitas N, Padial LR. Doppler echocardiographic assessment of long-term progression of mitral stenosis in 103 patients: valve area and right heart disease. J Am Coll Cardiol. 1996;28:472–479[Abstract]
  82. Fawzy ME, Mimish L, Sivanandam V. Immediate and long-term effect of mitral balloon valvotomy on severe pulmonary hypertension in patients with mitral stenosis. Am Heart J. 1996;131:89–93[CrossRef][Web of Science][Medline]
  83. Sugishita Y, Ito I, Kubo T. Pregnancy in cardiac patients: possible influence of volume overload by pregnancy on pulmonary circulation. Jpn Circ J. 1986;50:376–383[Medline]
  84. Avila WS, Grinberg M, Decourt LV, Bellotti G, Pileggi F. Evoluçao clinica de portadoras de estenose mitral no ciclo gravidico-puerperal. Arq Bras Cardiol. 1992;58:359–364[Medline]
  85. Ziskind Z, Etchin A, Frenkel Y. Epidural anesthesia with the Trendelenburg position for Caesarean section with or without a cardiac surgical procedure in patients with severe mitral stenosis: a hemodynamic study. J Cardiothorac Anesth. 1990;4:354–359[CrossRef][Medline]
  86. Hemmings GT, Whalley DG, O'Connor PJ, Benjamin A, Dunn C. Invasive monitoring and anaesthetic management of a parturient with mitral stenosis. Can J Anaesth. 1987;34:182–185[Web of Science][Medline]
  87. Ducey JP, Ellsworth SM. The hemodynamic effects of severe mitral stenosis and pulmonary hypertension during labor and delivery. Intensive Care Med. 1989;15:192–195[CrossRef][Web of Science][Medline]
  88. Al Kasab S, Sabag T, Al Zaibag M. ß-Adrenergic receptor blockade in the management of pregnant women with mitral stenosis. Am J Obstet Gynecol. 1990;163:37–40[Web of Science][Medline]
  89. Afrangui B, Malinow AM. Severe preclampsia complicating mitral valve stenosis. Reg Anesth Pain Med. 1998;23:204–209[Web of Science][Medline]
  90. Sia ATH, Chong JL, Tan CGM. Severe mitral stenosis in a parturient with congestive cardiac failure and hypoglycaemia. Int J Obstet Anesth. 1998;7:173–176[CrossRef][Web of Science][Medline]
  91. Batson MA, Longmire S, Csontos E. Alfentanil for urgent Caesarean section in a patient with severe mitral stenosis and pulmonary hypertension. Can J Anaesth. 1990;37:685–688[Web of Science][Medline]
  92. Lenoir B, Freiermuth C, Bonnet A, Marty J. Césarienne, maladie mitrale et hypertension artérielle pulmonaire. Implications du monitorage hémodynamique sur la conduite de l'anesthesie. Ann Fr Anesth Réanim. 1993;12:582–586[CrossRef][Web of Science][Medline]
  93. Weiss, BM, Rhomberg, P, Fehr, S, Pregnant patient with mitral stenosis 1989–1998
  94. Stephen SJ. Changing patterns of mitral stenosis in childhood and pregnancy in Sri Lanka. J Am Coll Cardiol. 1992;19:1276–1284[Abstract]
  95. Esteves CA, Ramos AI, Braga SL, Harrison JK, Sousa JE. Effectiveness of percutaneous balloon mitral valvotomy during pregnancy. Am J Cardiol. 1991;68:930–934[CrossRef][Web of Science][Medline]
  96. Sananes S, Iung B, Vahanian A, Acar J, Salat-Baroux J, Uzan S. Fetal and obstetrical impact of percutaneous balloon mitral commissurotomy during pregnancy. Fetal Diagn Ther. 1994;9:218–225[Web of Science][Medline]
  97. Gupta A, Lokhandwala YY, Satoskar PR, Salvi VS. Balloon mitral valvotomy in pregnancy: maternal and fetal outcomes. J Am Coll Surg. 1998;187:409–415[CrossRef][Web of Science][Medline]
  98. Martinez-Reding J, Cordero A, Kuri J, Martinez-Rios MA, Salazar E. Treatment of severe mitral stenosis with percutaneous balloon valvotomy in pregnant patients. Clin Cardiol. 1998;21:659–663[Web of Science][Medline]
  99. Gupta S, Vora A, Lokhandwalla Y. Percutaneous balloon mitral valvotomy in mitral restenosis. Eur Heart J. 1996;17:1560–1564[Abstract/Free Full Text]
  100. Oakley CM. Anticoagulants in pregnancy. Br Heart J. 1995;74:107–111[Free Full Text]
  101. Barbour LA, Pickard J. Controversies in thromboembolic disease during pregnancy: a critical review. Obstet Gynecol. 1995;86:621–633[Web of Science][Medline]
  102. Astedt. Antenatal drugs affecting vitamin K status of the fetus and the newborn. Semin Thromb Hemost. 1995;21:364–370[Web of Science][Medline]
  103. Greer IA. Epidemiology, risk factors and prophylaxis of venous thrombo-embolism in obstetrics and gynaecology. Baillière's Clin Obstet Gynaecol. 1997;11:403–430[CrossRef][Web of Science][Medline]
  104. Bates SM, Ginsberg JS. Anticoagulants in pregnancy: fetal effects. Baillière's Clin Obstet Gynaecol. 1997;11:479–488[CrossRef][Web of Science][Medline]
  105. Koren G, Pastuszak A, Ito S. Drugs in pregnancy. N Engl J Med. 1998;338:1128–1137[Free Full Text]
  106. Ginsberg JS, Hirsh J. Use of antithrombotic agents during pregnancy. Chest. 1998;114:524S–530S[Medline]
  107. Dulitzky M, Pauzner R, Langevitz P, Pras M, Many A, Schiff E. Low-molecular-weight heparin during pregnancy and delivery: preliminary experience with 41 pregnancies. Obstet Gynecol. 1996;87:380–383[CrossRef][Web of Science][Medline]
  108. Nelson-Piercy C, Letsky EA, de Swiet M. Low-molecular-weight heparin for obstetric thromboprophylaxis: experience of sixty-one pregnancies in sixty-one women at high risk. Am J Obstet Gynecol. 1997;176:1062–1068[CrossRef][Web of Science][Medline]
  109. LéCuru F, Desnos M, Taurelle R. Anticoagulant therapy in pregnancy: report of 54 cases. Acta Obstet Gynecol Scand. 1996;75:217–221[Web of Science][Medline]
  110. Nelson-Piercy C. Hazards of heparin: allergy, heparin-induced thrombocytopenia and osteoporosis. Baillière's Clin Obstet Gynaecol. 1997;11:489–509[CrossRef][Web of Science][Medline]
  111. Macklon NS, Greer IA, Bowman AW. An ultrasound study of gestational and postural changes in the deep venous system of the leg in pregnancy. Br J Obstet Gynaecol. 1997;104:191–197[Web of Science][Medline]
  112. Sharma SK, Phillip J, Wiley J. Thromboelastographic changes in healthy parturients and postpartum women. Anesth Analg. 1997;85:94–98[Abstract]
  113. Bellart J, Gilabert R, Fontcuberta J, Carreras E, Miralles RM, Cabero L. Coagulation and fibrinolytic parameters in normal pregnancy and in pregnancy complicated by intrauterine growth retardation. Am J Perinatol. 1998;15:81–85[Web of Science][Medline]
  114. Letsky EA. Peripartum prophylaxis of thrombo-embolism. Baillière's Clin Obstet Gynaecol. 1997;11:523–543[CrossRef][Web of Science][Medline]
  115. Grubb NR, Bloomfield P, Ludlam CA. The end of the heparin pump? Low molecular weight heparin has many advantages over unfractionated heparin (editorial). BMJ. 1998;317:1540–1542[Free Full Text]
  116. Beilin Y, Zahn J, Comerford M. Safe epidural analgesia in thirty parturients with platelet counts between 69,000 and 98,000mm–3. Anesth Analg. 1997;85:385–388[Abstract]
  117. Horlocker TT, Wedel DK. Anticoagulation and neuroaxial block: historical perspective, anesthetic implications, and risk management. Reg Anesth Pain Med. 1998;23:129–134[CrossRef][Web of Science][Medline]
  118. Perloff JK. Systemic complications of cyanosis in adults with congenital heart disease. Hematologic derangements, renal function, and urate metabolism. Cardiol Clin. 1993;11:689–699[Medline]
  119. Haroutunian LM, Neill CA. Pulmonary complications of congenital heart disease: hemoptysis. Am Heart J. 1972;84:540–559[CrossRef][Web of Science][Medline]
  120. Leung WH, Lau CP, Wong CK, Cheng CH. Fatal massive pulmonary hemorrhage complicating mitral stenosis. Clin Cardiol. 1990;13:136–138[Web of Science][Medline]
  121. Waring PH, Shaw DB, Brumfield CG. Anesthetic management of a parturient with Osler-Weber-Rendu syndrome and rheumatic heart disease. Anesth Analg. 1990;71:96–99[Free Full Text]
  122. Downs TW, Chao CR. Massive hemoptysis in pregnancy treated with bronchial embolization. Am J Perinatol. 1997;14:51–53[Web of Science][Medline]
  123. Leonard H, O'Sullivan JJ, Hunter S. Family planning requirements in the adult congenital heart disease clinic. Heart. 1996;76:60–62[Abstract/Free Full Text]
  124. Tio I, Tewari K, Balderston KD, Milliken JC, Porto M. Emergency mitral valve replacement in the setting of severe pulmonary hypertension and acute cardiovascular decompensation after evacuation of twins at fifteen weeks' gestation. Am J Obstet Gynecol. 1998;179:270–272[CrossRef][Web of Science][Medline]
  125. Popijn M, Hensenne A, Gibon M. Hypertension artérielle pulmonaire primitive et grossesse. Á propos d'une observation. J Gynecol Obstet Reprod Biol. 1991;20:691–694
  126. Raines DE, Liberthson RR, Murray JR. Anesthetic management and outcome following noncardiac surgery in nonparturients with Eisenmenger's physiology. J Clin Anesth. 1996;8:341–347[CrossRef][Web of Science][Medline]
  127. Myles PS. Anaesthetic management of laparoscopic sterilisation and termination of pregnancy in a patient with severe primary pulmonary hypertension. Anaesth Intens Care. 1994;22:465–469[Web of Science][Medline]
  128. Temelcos C, Kuhn R, Stribley C. Sterilization of women with Eisenmenger syndrome: report of 4 cases. Aust NZ J Obstet Gynaecol. 1997;37:121–123[Web of Science][Medline]
  129. Weiss BM, Atanassoff PG, Jenni R, Walder B, Wight E. Pulmonary atresia with ventricular septal defect: a case for central venous pressure and oxygen saturation monitoring. Yale J Biol Med. 1998;71:15–21[Web of Science][Medline]
  130. Ammash NM, Connolly HM, Abel MD, Warnes CA. Noncardiac surgery in Eisenmenger syndrome. J Am Coll Cardiol. 1999;33:222–227[Abstract/Free Full Text]
  131. Kerstein D, Levy PS, Hsu DT, Hordorf AJ, Gersony WM, Barst RJ. Blade balloon atrial septostomy in patients with severe primary pulmonary hypertension. Circulation. 1995;91:2028–2035[Abstract/Free Full Text]
  132. Sandoval J, Gaspar J, Pulido T. Graded balloon dilation atrial septostomy in severe primary pulmonary hypertension. A therapeutic alternative for patients nonresponsive to vasodilator treatment. J Am Coll Cardiol. 1998;32:297–304[Abstract/Free Full Text]
  133. Moser KM, Auger WR, Fedullo PF, Jamieson SW. Chronic thromboembolic pulmonary hypertension: clinical picture and surgical treatment. Eur Respir J. 1992;5:334–342[Abstract]
  134. Johnson MR, Naftel DC, Hobbs RE. The incremental risk of female sex in heart transplantation: a multiinstutitional study of peripartum cardiomyopathy and pregnancy. Cardiac Transplant Research Database Group. J Heart Lung Transpl. 1997;16:801–812[Web of Science][Medline]
  135. Chinayon P, Sakornpant P. Successful pregnancy after heart-lung transplantation. Asia Oceania J Obstet Gynaecol. 1994;20:275–278[Medline]
  136. Troche V, Ville Y, Fernandez H. Pregnancy after heart or heart-lung transplantation: a series of 10 pregnancies. Br J Obstet Gynaecol. 1998;105:454–458[Web of Science][Medline]
  137. Inbar S, Schrader BJ, Kaufmann E, Vestal RE, Rich S. Effects of adenosine in combination with calcium channel blockers in patients with primary pulmonary hypertension. J Am Coll Cardiol. 1993;21:413–418[Abstract]
  138. Friedman R, Mears JG, Barst RJ. Continuous infusion of prostacyclin normalizes plasma markers of endothelial cell injury and platelet aggregation in primary pulmonary hypertension. Circulation. 1997;96:2782–2784[Abstract/Free Full Text]
  139. Kunimoto F, Arai K, Isa Y. A comparative study of the vasodilator effects of prostaglandin E1 in patients with pulmonary hypertension after mitral valve replacement and with adult respiratory distress syndrome. Anesth Analg. 1997;85:507–513[Abstract]
  140. Girard C, Lefot JJ, Pannetier JC, Filley S, Ffrench P, Estanove S. Inhaled nitric oxide after mitral valve replacement in patients with chronic pulmonary artery hypertension. Anesthesiology. 1992;77:880–883[CrossRef][Web of Science][Medline]
  141. Olschewski H, Walmrath D, Schermuly R, Ghofrani A, Grimminger F, Seeger W. Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med. 1996;124:820–824[Abstract/Free Full Text]
  142. Mikhail G, Gibbs JSR, Richardson M. An evaluation of nebulized prostacyclin in patients with primary and secondary pulmonary hypertension. Eur Heart J. 1997;18:1499–1504[Abstract/Free Full Text]
  143. Gildein HP, Wildberg A, Mocellin R. Vergleichende Untersuchungen der Hämodynamik unter Prostazyklin und Nifedipin bei Patienten mit Eisenmenger-Syndrom. Z Kardiol. 1995;84:55–63[Web of Science][Medline]
  144. Atz AM, Adatia I, Lock JE, Wesel DL. Combined effects of nitric oxide and oxygen during acute pulmonary vascular testing. J Am Coll Cardiol. 1999;33:813–819[Abstract/Free Full Text]
  145. Rozenzweig EB, Kerstein D, Barst RJ. Long-term prostacyclin for pulmonary hypertension with associated congenital heart defects. Circulation. 1999;99:1858–1865[Abstract/Free Full Text]
  146. Castro PF, Bourge RC, McGiffin DC. Intrapulmonary shunting in primary pulmonary hypertension. An observation in two patients treated with epoprostenol sodium. Chest. 1998;114:334–336[Medline]
  147. Gries A, Bode C, Peter K. Inhaled nitric oxide inhibits human platelet aggregation, P-selectin expression, and fibrinogen binding in vitro and in vivo. Circulation. 1998;97:1481–1487[Abstract/Free Full Text]
  148. Wanecek M, Rudehill A, Hemsen A, Lundberg JM, Weitzberg E. The endothelin receptor antagonist, bosentan, in combination with the cyclooxygenase inhibitor, diclofenac, counteracts pulmonary hypertension in porcine endotoxin shock. Crit Care Med. 1997;25:848–857[CrossRef][Web of Science][Medline]
  149. Holm P, Liska J, FrancoCereceda A. The ATA receptor antagonist, BMS-182874, reduces acute hypoxic pulmonary hypertension in pigs in vivo. Cardiovasc Res. 1998;37:765–771[Abstract/Free Full Text]
  150. Dupuis J, Cernacek P, Tardif JC. Reduced pulmonary clearance of endothelin-1 in pulmonary hypertension. Am Heart J. 1998;135:614–620[CrossRef][Web of Science][Medline]
  151. Giaid A. Nitric oxide and endothelin-1 in pulmonary hypertension. Chest. 1998;114:208S–212S[CrossRef][Web of Science][Medline]
  152. N Engl J Med. 1999;340:455–464[Free Full Text]
  153. Robinson JN, Banerjee R, Landzberg MJ, Thiet MP. Inhaled nitric oxide therapy in pregnancy complicated by pulmonary hypertension. Am J Obstet Gynecol. 1999;180:64–67[CrossRef][Web of Science][Medline]
  154. Easterling TR, Ralph DD, Schmucker BC. Pulmonary hypertension in pregnancy: treatment with pulmonary vasodilators. Obstet Gynecol. 1999;93:494–498[CrossRef][Web of Science][Medline]
  155. O'Hare R, McLoghlin C, Milligan K, McNamee D, Sidhu H. Anaesthesia for Caesarean section in the presence of severe primary pulmonary hypertension. Br J Anaeth. 1998;81:790–792[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 Rheumatology (Oxford)Home page
A. Prabu, K. Patel, C.-S. Yee, P. Nightingale, R. D. Situnayake, D. R. Thickett, J. N. Townend, and C. Gordon
Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus
Rheumatology, December 1, 2009; 48(12): 1506 - 1511.
[Abstract] [Full Text] [PDF]

Home page
 Eur Heart JHome page
E. Bedard, K. Dimopoulos, and M. A. Gatzoulis
Has there been any progress made on pregnancy outcomes among women with pulmonary arterial hypertension?
Eur. Heart J., February 1, 2009; 30(3): 256 - 265.
[Abstract] [Full Text] [PDF]

Home page
 CirculationHome page
C. L. Verheugt, C. S.P.M. Uiterwaal, E. T. van der Velde, F. J. Meijboom, P. G. Pieper, H. W. Vliegen, A. P.J. van Dijk, B. J. Bouma, D. E. Grobbee, and B. J.M. Mulder
Gender and Outcome in Adult Congenital Heart Disease
Circulation, July 1, 2008; 118(1): 26 - 32.
[Abstract] [Full Text] [PDF]

Home page
 HeartHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Heart, March 1, 2008; 94(Suppl_1): i1 - i41.
[Full Text] [PDF]

Home page
 ThoraxHome page
National Pulmonary Hypertension Centres of the UK
Consensus statement on the management of pulmonary hypertension in clinical practice in the UK and Ireland
Thorax, March 1, 2008; 63(Suppl_2): ii1 - ii41.
[Full Text] [PDF]

Home page
 Am. J. Respir. Crit. Care Med.Home page
I. D. Wexler, M. Johannesson, F. P. Edenborough, B. S. Sufian, and E. Kerem
Pregnancy and Chronic Progressive Pulmonary Disease
Am. J. Respir. Crit. Care Med., February 15, 2007; 175(4): 300 - 305.
[Abstract] [Full Text] [PDF]

Home page
 Postgrad. Med. J.Home page
C E G Head and S A Thorne
Congenital heart disease in pregnancy
Postgrad. Med. J., May 1, 2005; 81(955): 292 - 298.
[Abstract] [Full Text] [PDF]

Home page
 Br J AnaesthHome page
P. Ray, G. J. Murphy, and L. E. Shutt
Recognition and management of maternal cardiac disease in pregnancy
Br. J. Anaesth., September 1, 2004; 93(3): 428 - 439.
[Abstract] [Full Text] [PDF]

Home page
 ChestHome page
R. Stewart, D. Tuazon, G. Olson, and A. G. Duarte
Pregnancy and Primary Pulmonary Hypertension : Successful Outcome With Epoprostenol Therapy
Chest, March 1, 2001; 119(3): 973 - 975.
[Abstract] [Full Text] [PDF]

This Article
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Weiss, B.M
Right arrow Articles by Hess, O.M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Weiss, B.M
Right arrow Articles by Hess, O.M
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?